// App-Quantinova.ai

: Initial Clinical Evaluation of VC-01TM Combination Product—A Stem Cell–Derived Islet Replacement for Type 1 Diabetes (T1D)

Researchers

Presenter

  • ROBERT R. HENRY

Principal Investigators

  • JEREMY PETTUS

  • JON WILENSKY

  • A.M. JAMES SHAPIRO

  • PETER A. SENIOR

  • BART ROEP

  • RICHARD WANG

  • EVERT J. KROON

  • MICHAEL SCOTT

  • KEVIN D'AMOUR

Medical Centers

  • N/A

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Intranasal glucagon

  • VC01

Outcome

  • N/A

Study Design

  • Adaptive

  • Open Label

  • Cohort

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved